These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11134507)

  • 1. Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo.
    Silletti S; Kessler T; Goldberg J; Boger DL; Cheresh DA
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):119-24. PubMed ID: 11134507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
    Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.
    Maeshima Y; Colorado PC; Kalluri R
    J Biol Chem; 2000 Aug; 275(31):23745-50. PubMed ID: 10837460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3).
    Boger DL; Goldberg J; Silletti S; Kessler T; Cheresh DA
    J Am Chem Soc; 2001 Feb; 123(7):1280-8. PubMed ID: 11456699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
    Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
    Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel disintegrin salmosin inhibits tumor angiogenesis.
    Kang IC; Lee YD; Kim DS
    Cancer Res; 1999 Aug; 59(15):3754-60. PubMed ID: 10446992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
    Yeh CH; Peng HC; Yang RS; Huang TF
    Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2.
    Leroy-Dudal J; Demeilliers C; Gallet O; Pauthe E; Dutoit S; Agniel R; Gauduchon P; Carreiras F
    Int J Cancer; 2005 Apr; 114(4):531-43. PubMed ID: 15609323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.
    Brooks PC; Strömblad S; Sanders LC; von Schalscha TL; Aimes RT; Stetler-Stevenson WG; Quigley JP; Cheresh DA
    Cell; 1996 May; 85(5):683-93. PubMed ID: 8646777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
    Belvisi L; Riccioni T; Marcellini M; Vesci L; Chiarucci I; Efrati D; Potenza D; Scolastico C; Manzoni L; Lombardo K; Stasi MA; Orlandi A; Ciucci A; Nico B; Ribatti D; Giannini G; Presta M; Carminati P; Pisano C
    Mol Cancer Ther; 2005 Nov; 4(11):1670-80. PubMed ID: 16275988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase.
    Deryugina EI; Ratnikov BI; Postnova TI; Rozanov DV; Strongin AY
    J Biol Chem; 2002 Mar; 277(12):9749-56. PubMed ID: 11724803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Becker JC; Ruiter DJ; van Muijen GN
    J Invest Dermatol; 2000 Oct; 115(4):625-32. PubMed ID: 10998134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.
    Brooks PC; Silletti S; von Schalscha TL; Friedlander M; Cheresh DA
    Cell; 1998 Feb; 92(3):391-400. PubMed ID: 9476898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.
    Carron CP; Meyer DM; Pegg JA; Engleman VW; Nickols MA; Settle SL; Westlin WF; Ruminski PG; Nickols GA
    Cancer Res; 1998 May; 58(9):1930-5. PubMed ID: 9581835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Click-chemistry-derived triazole ligands of arginine-glycine-aspartate (RGD) integrins with a broad capacity to inhibit adhesion of melanoma cells and both in vitro and in vivo angiogenesis.
    Trabocchi A; Menchi G; Cini N; Bianchini F; Raspanti S; Bottoncetti A; Pupi A; Calorini L; Guarna A
    J Med Chem; 2010 Oct; 53(19):7119-28. PubMed ID: 20809642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical.
    Nisato RE; Hosseini G; Sirrenberg C; Butler GS; Crabbe T; Docherty AJ; Wiesner M; Murphy G; Overall CM; Goodman SL; Pepper MS
    Cancer Res; 2005 Oct; 65(20):9377-87. PubMed ID: 16230401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo.
    Xu J; Rodriguez D; Petitclerc E; Kim JJ; Hangai M; Moon YS; Davis GE; Brooks PC
    J Cell Biol; 2001 Sep; 154(5):1069-79. PubMed ID: 11535623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thalidomide on parameters involved in angiogenesis: an in vitro study.
    Gelati M; Corsini E; Frigerio S; Pollo B; Broggi G; Croci D; Silvani A; Boiardi A; Salmaggi A
    J Neurooncol; 2003 Sep; 64(3):193-201. PubMed ID: 14558594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.
    Kaliski A; Maggiorella L; Cengel KA; Mathe D; Rouffiac V; Opolon P; Lassau N; Bourhis J; Deutsch E
    Mol Cancer Ther; 2005 Nov; 4(11):1717-28. PubMed ID: 16275993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly invasive melanoma cells activate the vascular endothelium via an MMP-2/integrin αvβ5-induced secretion of VEGF-A.
    Desch A; Strozyk EA; Bauer AT; Huck V; Niemeyer V; Wieland T; Schneider SW
    Am J Pathol; 2012 Aug; 181(2):693-705. PubMed ID: 22659470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.